产前外显子组测序在MRI和超声检测的胎儿脑异常遗传筛查中的诊断率:系统综述与荟萃分析
该系统综述与荟萃分析纳入11项研究共779例胎儿,评估外显子组测序(ES)在影像学检测的胎儿脑异常中的诊断率并与染色体微阵列分析(CMA)比较。ES汇总诊断率为26.53%,CMA为3.46%;复杂脑异常的ES与CMA风险差为0.36(95%CI 0.24-0.47),高于单一脑异常的0.22(95%CI 0.18-0.25)。结论认为ES是有效方法,对复杂脑异常诊断率显著高于CMA。
要点
- 影像学检测的胎儿脑异常中,ES汇总诊断率为26.53%,CMA为3.46%。
- 复杂脑异常ES与CMA风险差0.36(95%CI 0.24-0.47),高于单一脑异常的0.22(95%CI 0.18-0.25)。
- ES对复杂脑异常的诊断率显著高于CMA,可用于有相关家族史的疑似胎儿。
核心结论
- ES是有效方法,对影像学检测的复杂脑异常胎儿遗传评估的诊断率显著高于CMA。
- ES可应用于有相关家族史的疑似胎儿以高效预测先天性疾病。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Web of Science和Embase三个数据库。
- 纳入依据STARD清单的11项研究,共779例胎儿,均实施ES联合影像技术。
- 采用随机效应模型进行荟萃分析,并以亚组分析确定ES与CMA之间的风险差。
主要发现
- 经MRI和超声检测的胎儿脑异常中,ES汇总诊断率为26.53%,CMA为3.46%。
- 复杂脑异常ES与CMA的风险差为0.36(95%CI 0.24-0.47)。
- 单一脑异常ES与CMA的风险差为0.22(95%CI 0.18-0.25)。
关键数值与推荐
- 纳入研究依据STARD清单,并计算ES与CMA的诊断率。
临床怎么用
- 作者认为ES是有效方法,对影像学检测的复杂脑异常胎儿遗传评估的诊断率显著高于CMA。
- 作者认为ES可应用于有相关家族史的疑似胎儿以高效预测先天性疾病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brain anomalies (BAs) have been the focus of research, as they have a high impact on fetal health but therapeutic and diagnostic approaches are limited. OBJECTIVES: In this study, the application and efficiency of exome sequencing (ES) in detecting different cases of BAs in fetuses were evaluated and compared with chromosomal microarray analysis (CMA). SEARCH STRATEGY: To conduct this study, three databases including PubMed, Web of Science and Embase were utilised with the keywords 'prenatal', 'diagnoses', 'brain anomalies' and 'exome sequencing'. SELECTION CRITERIA: Studies were included based on the STARD checklist, for which the ES and CMA diagnostic yields were calculated. DATA COLLECTION AND ANALYSIS: Meta-analysis was performed on the included studies using a random-effects model and subgroup analysis to define the risk difference between them. MAIN RESULTS: We included 11 studies representing 779 fetuses that implemented ES along with imaging techniques. The pooled ES diagnostic yield in fetuses with BAs detected through magnetic resonance imaging (MRI) and ultrasonography was 26.53%, compared with 3.46% for CMA. The risk difference between ES and CMA for complex BAs was 0.36 [95% confidence interval (CI) 0.24-0.47], which was higher than for single BAs (0.22; 95% CI 0.18-0.25]. CONCLUSIONS: ES is a useful method with a significantly higher diagnostic yield than CMA for genetic assessment of fetuses with complex BAs detected by imaging techniques. Moreover, ES could be applied to suspected fetuses with related family histories to predict congenital diseases with high efficiency.
引用
- Moradi B, Ariaei A, Heidari-Foroozan M, et al. Diagnostic yield of prenatal exome sequencing in the genetic screening of fetuses with brain anomalies detected by MRI and ultrasonography: A systematic review and meta-analysis. BJOG. 2023. PMID: 37932235. doi:10.1111/1471-0528.17710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。